Literature DB >> 12534582

Decreased sTNF-RI in migraine patients?

M Empl1, P Sostak, M Riedel, M Schwarz, N Müller, S Förderreuther, A Straube.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) have recently been found to have a pain-mediating function in addition to their immunological, proinflammatory function. According to the hypothesis of neurovascular inflammation in migraine, these two cytokines could contribute to migraine pain generation. We analysed IL-6 and its soluble receptors sIL-6R and sgp130 as well as TNF-alpha and its soluble receptor sTNF-RI in 27 migraine patients and eight headache-free controls. Migraine patients tended to have less sTNF-RI (794 +/- 158 pg/ml) than controls (945 +/- 137 pg/ml). No differences in cytokine concentrations were observed. If TNF-alpha plays a role in migraine physiopathology, migraine patients may lack sufficient antagonistic sTNF-RI to neutralize hyperalgesic TNF-alpha during a migraine attack.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534582     DOI: 10.1046/j.1468-2982.2003.00453.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

Review 1.  Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert Yl Zee; Daniel I Chasman; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-10       Impact factor: 6.292

2.  Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons.

Authors:  Elizabeth J Bowen; Thomas W Schmidt; Christina S Firm; Andrew F Russo; Paul L Durham
Journal:  J Neurochem       Date:  2005-11-08       Impact factor: 5.372

3.  [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].

Authors:  M Empl; A Straube
Journal:  Schmerz       Date:  2007-10       Impact factor: 1.107

4.  Non-invasively triggered spreading depolarizations induce a rapid pro-inflammatory response in cerebral cortex.

Authors:  Tsubasa Takizawa; Tao Qin; Andreia Lopes de Morais; Kazutaka Sugimoto; Joon Yong Chung; Liza Morsett; Inge Mulder; Paul Fischer; Tomoaki Suzuki; Maryam Anzabi; Maximilian Böhm; Wen-Sheng Qu; Takeshi Yanagisawa; Suzanne Hickman; Joseph El Khoury; Michael J Whalen; Andrea M Harriott; David Y Chung; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-26       Impact factor: 6.200

5.  The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Authors:  Fahimeh Martami; Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Maryam Seifishahpar; Atoosa Saidpour
Journal:  Neurol Sci       Date:  2018-07-15       Impact factor: 3.307

6.  Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine.

Authors:  Kinga Gecse; Andrea Edit Édes; Tamás Nagy; Adrienn Katalin Demeter; Dávid Virág; Márton Király; Borbála Dalmadi Kiss; Krisztina Ludányi; Zsuzsanna Környei; Adam Denes; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Cells       Date:  2022-07-21       Impact factor: 7.666

7.  Investigation of the NOTCH3 and TNFSF7 genes on C19p13 as candidates for migraine.

Authors:  Robert A Smith; Robert Curtain; Mick Ovcaric; Lotti Tajouri; John Macmillan; Lyn Griffiths
Journal:  Open Neurol J       Date:  2008-04-23

Review 8.  Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research.

Authors:  Eleonóra Spekker; Masaru Tanaka; Ágnes Szabó; László Vécsei
Journal:  Biomedicines       Date:  2021-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.